EXCLUSIVE: Sarah Dodge has joined Redefine Entertainment as a manager. She joins the company with over 12 years of experience ...
Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback